CJC1295 wo/DAC

$40.00

CJC-1295 without DAC, commonly referred to as MOD-GRF 1-29, is a synthetic analog of Growth Hormone–Releasing Hormone (GHRH) designed to stimulate natural growth hormone (GH) secretion.

Unlike the DAC version, it does not contain the Drug Affinity Complex modification, so it has a much shorter half-life and mimics the body’s natural GH pulse pattern more closely.

It is widely used in laboratory research on endocrine signaling and growth hormone physiology.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

SKU: N/A Category:

🧬 What CJC-1295 w/o DAC Is

CJC-1295 without DAC, commonly referred to as MOD-GRF 1-29, is a synthetic analog of Growth Hormone–Releasing Hormone (GHRH) designed to stimulate natural growth hormone (GH) secretion.

Unlike the DAC version, it does not contain the Drug Affinity Complex modification, so it has a much shorter half-life and mimics the body’s natural GH pulse pattern more closely.

It is widely used in laboratory research on endocrine signaling and growth hormone physiology.


⚙️ Mechanism of Action

CJC-1295 w/o DAC stimulates GH release through normal physiological pathways.


🔹 GHRH Receptor Activation

It binds to GHRH receptors in the pituitary gland, leading to:

  • Increased GH release

  • Enhanced amplitude of natural GH pulses

This preserves normal feedback mechanisms involving somatostatin and IGF-1.


🔹 Short Half-Life / Pulsatile Signaling

Without DAC, its half-life is about 30 minutes.

This allows researchers to study:

  • Natural GH pulse dynamics

  • Endocrine feedback loops

  • Combination effects with GHRP peptides

It is often studied alongside peptides like Ipamorelin in research models.


🔹 Downstream IGF-1 Effects

Increased GH leads to IGF-1 production in the liver, influencing:

  • Protein synthesis signaling

  • Tissue repair pathways

  • Fat metabolism

These downstream effects are similar to natural GH physiology.


📊 Research Evidence & Experimental Findings

CJC-1295 w/o DAC has been studied mainly in research settings, with less formal clinical trial data than the DAC version.


📌 Growth Hormone Studies

Research shows it can:

  • Increase GH secretion

  • Enhance GH pulse amplitude

  • Increase IGF-1 levels modestly

Because of its short action, effects are more transient than DAC versions.


📌 Combination Research

MOD-GRF 1-29 is often studied with GHRP peptides (e.g., Ipamorelin or GHRP-6) to examine synergistic GH release.

These combinations mimic natural GH regulatory cycles.


📌 Endocrine Physiology Research

CJC-1295 w/o DAC is used to study:

  • Pituitary hormone regulation

  • Aging-related GH decline

  • Metabolic and sleep-related GH signaling


🧪 Safety & Side Effects

There is limited formal clinical safety data.


⚠️ Possible Effects

Similar to GH-related signaling:

  • Injection site irritation

  • Headache

  • Flushing

  • Mild nausea


⚠️ Hormonal-Related Risks

Because GH and IGF-1 may increase:

  • Water retention

  • Joint discomfort

  • Insulin sensitivity changes

Long-term safety data are lacking.


⚠️ Unknowns

  • Long-term endocrine effects

  • Effects in different populations

  • Optimal dosing patterns

More research is needed.


⚖️ Regulatory Status

  • Not FDA-approved as a therapeutic drug.

  • Investigated in research and clinical studies.

  • Sold in some contexts as a research compound.

  • Banned by the World Anti-Doping Agency (WADA).

It is not approved for general medical use.


🔚 Bottom Line

  • CJC-1295 w/o DAC (MOD-GRF 1-29) is a short-acting GHRH analog that stimulates natural GH pulses.

  • It mimics physiological GH release more closely than DAC versions.

  • It is used in endocrine and metabolic research models.

  • It is not approved for medical use and remains a research-stage compound.

Strength

2mg, 5mg, 10mg, 5mg Kit (10 Vials), 10mg Kit (10 Vials)

Reviews

There are no reviews yet.

Be the first to review “CJC1295 wo/DAC”

Your email address will not be published. Required fields are marked *